I believe I'm in the count from near it's beginning, so I won't add myself now. I also believe that we got efficacy trial results in their roughest form, the trial went great. Results will be refined, no doubt their will be photo's in a presentation, but that will happen when the opportunity is teir for peer review.
For now, I believe their is a lot to look forward to in the next few weeks, namely the Annual Report. I suspect some additional information on the trial will be provided then, or in a webcast should one occur with it's release. Additionally we should get the company's plan of action not just for the psoriasis cream, but for all their products in the near term. We should also get their plans financially.
Some here would have us thinking they're broke, others know they spoke of having $2 million at the time of the Wall St. conference a few weeks ago. I believe they probably have the majority of that left, but to get it they probably sold shares, so we really don't know precisely the O/S right now.
Remember the Market Cap is the product of the shares outstanding times the current price. Right now, from what we know, we'll hit $1 billion at about $7. When people talk about $100 share prices they're speaking about a market cap of roughly $15 billion, it's possible, but it will take earnings approaching a billion, with a reasonable P/E, that will take some time.
Gary
Market Data 
Markets 
AI
